A patient is suffering from ADA deficiency. Can he be cured? How?
A patient is suffering from ADA deficiency. Can he be cured? How?
The first clinical gene therapy was given in 1990 to a 4-year old girl with adenosine deaminase (ADA) deficiency. This enzyme is crucial for the immune system to function. The disorder is caused due to the deletion of the gene for adenosine deaminase. In some children ADA deficiency can be cured by bone marrow transplantation; in others it can be treated by enzyme replacement therapy, in which functional ADA is given to the patient by injection. But the problem with both of these approaches that they are not completely curative. As a first step towards gene therapy, lymphocytes from the blood of the patient are grown in a culture outside the body. A functional ADA cDNA (using a retroviral vector) is then introduced into these lymphocytes, which are subsequently returned to the patient. However, as these cells are not immortal, the patient requires periodic infusion of such genetically engineered lymphocytes. However, if the gene isolate from marrow cells producing ADA is introduced into cells at early embryonic stages, it could be a permanent cure.
-
Name the five key tools for accomplishing the tasks of recombinant DNA technology. Also, mention the functions of each tool.
3 years ago
-
What is meant by the term bio-pesticide? Name and explain the mode of action of a popular bio-pesticide.
3 years ago
-
List the advantages of recombinant insulin.
3 years ago
-
List the disadvantages of insulin obtained from the pancreas of slaughtered cows and pigs.
3 years ago
-
Explain with the help of one example how genetically modified plants can: (a) Reduce usage of chemical pesticides (b) Enhance nutritional value of food crops
3 years ago
- 321 Forums
- 27.3 K Topics
- 53.8 K Posts
- 0 Online
- 12.4 K Members